價(jià)格 | 詢價(jià) |
包裝 | 5μg |
最小起訂量 | 5μg |
發(fā)貨地 | 上海 |
更新日期 | 2024-11-05 |
中文名稱:Recombinant Human TACI/TNFRSF13B | 英文名稱:Recombinant Human TACI/TNFRSF13B |
有效期: 一年 | 產(chǎn)品類別: 重組蛋白 細(xì)胞因子 |
產(chǎn)品編號(hào) | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價(jià)格 |
P5408-5μg | Recombinant Human TACI/TNFRSF13B | 5μg | 464.00元 |
Species | Gene ID | Accession | Source | Length | MW | Tag |
Human | 23495 | O14836 | E. coli | 160aa | 18kDa | - |
About this Antibody | |
Name | Recombinant Human TACI/TNFRSF13B (Recombinant Human Transmembrane Activator and CAML Interactor/TNFRSF13B; rHuTACI/TNFRSF13B);重組人跨膜激活與CAML 作用因子/TNFRSF13B |
Synonyms | CD267; CVID; TNFRSF13B; CD267; CD267 antigen; CVID; CVID2; FLJ39942; MGC133214; TACIMGC39952; TNFRSF14B; Transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily, member 13B |
Purity | >95% by SDS-PAGE and HPLC analyses. |
Biological Activity | Fully biologically active when compared to standard. The biological activity is determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0μg/ml. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH7.4. |
Endotoxin | Less than 1EU/μg of rHuTACI/TNFRSF13B as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions. |
Category | Cytokine |
Background | TACI, transmembrane activator and CAML-interactor, is a member of the TNF receptor superfamily (TNFRSF). Within the TNFRSF, it shares the highest homology with BCMA. TACI and BCMA both bind APRIL and BLyS/BAFF, members of the TNF superfamily. TACI is expressed on the cell surface of B cells and activated, but not resting, T cells. Human TACI shares 54% amino acid sequence identity with murine TACI. |
Amino Acid Sequence | MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV |
包裝清單:
產(chǎn)品編號(hào) | 產(chǎn)品名稱 | 包裝 |
P5408-5μg | Recombinant Human TACI/TNFRSF13B | 5μg |
P5408-20μg | Recombinant Human TACI/TNFRSF13B | 20μg |
P5408-100μg | Recombinant Human TACI/TNFRSF13B | 100μg |
P5408-1mg | Recombinant Human TACI/TNFRSF13B | 1mg |
- | 說(shuō)明書 | 1份 |
保存條件:
???????-20℃或更低溫度保存,至少一年有效。由于蛋白的每次凍融均會(huì)引起部分失活,所以首次配制成相應(yīng)濃度的儲(chǔ)存液后(請(qǐng)根據(jù)產(chǎn)品簡(jiǎn)介中Reconstitution一欄的信息配制儲(chǔ)存液),須分裝后-20℃或更低溫度凍存,以避免反復(fù)凍融。
注意事項(xiàng):
???????由于有些塑料管壁對(duì)某些蛋白有較強(qiáng)的吸附作用,溶液中的蛋白很容易粘附在管壁上,并且粘附后的蛋白很難與管壁分離。而載體蛋白(Carrier protein,如0.1% BSA等)的主要作用是預(yù)先封閉塑料管壁上的蛋白結(jié)合位點(diǎn),使細(xì)胞因子或重組蛋白不會(huì)粘附于管壁。所以一定要使用產(chǎn)品簡(jiǎn)介中Reconstitution一欄的信息配制儲(chǔ)存液。
???????本產(chǎn)品僅限于專業(yè)人員的科學(xué)研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內(nèi)。
???????為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。
成立日期 | 2007-07-19 (18年) | 注冊(cè)資本 | 1000.000000萬(wàn)人民幣 |
員工人數(shù) | 500人以上 | 年?duì)I業(yè)額 | ¥ 500萬(wàn)-1000萬(wàn) |
主營(yíng)行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學(xué),生物活性小分子 | 經(jīng)營(yíng)模式 | 試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2024-11-18 | |
詢價(jià) |
湖北艾普蒂生物工程有限公司
|
2024-02-21 | ||
詢價(jià) |
VIP4年
|
上海冠導(dǎo)生物工程有限公司
|
2024-11-18 | |
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2024-11-18 | |
¥1950 |
VIP3年
|
上海滬震實(shí)業(yè)有限公司
|
2024-11-18 |